AI assistant
Sending…
ACHIEVE LIFE SCIENCES, INC. — Director's Dealing 2022
Jan 5, 2022
33882_dirs_2022-01-05_4462b61a-949d-4563-afd6-f3fecbbc0411.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ACHIEVE LIFE SCIENCES, INC. (ACHV)
CIK: 0000949858
Period of Report: 2022-01-03
Reporting Person: Bencich John (Director, CEO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-01-03 | Performance Restricted Stock Unit (PRSU) | $ | A | 50000 | Acquired | 2026-01-03 | Common Stock (50000) | Direct |
| 2022-01-03 | Stock Option (right to buy) | $8.26 | A | 50000 | Acquired | 2032-01-03 | Common Stock (50000) | Direct |
Footnotes
F1: Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement.
F2: Pursuant to the terms of the PRSU 50% of the total shares underlying the PRSU vest on the achievement of a performance-based milestone, and 50% vest on the first anniversary of the achievement of such milestone. The PRSUs will lapse in full if achievement of such milestone is not met.
F3: The options vest one-third on the first anniversary of January 3, 2022 and thereafter in monthly installments over 24 months.
More from ACHIEVE LIFE SCIENCES, INC.
Board/Management Information
2026
Jun 2
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Capital/Financing Update
2026
Apr 16
Annual Report
2026
Mar 24
Earnings Release
2026
Mar 24
Director's Dealing
2026
Jan 30
Director's Dealing
2026
Jan 30
Director's Dealing
2026
Jan 30
Director's Dealing
2026
Jan 30